Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,995 public trials 1,209 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Recruiting

A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

NCT06887348

Conditions: Adenocarcinoma, Advanced Solid Tumor, Carcinoma, +20 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

Tasman Oncology Research Southport, Queensland, Australia

View Trial Details

Recruiting

A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma

NCT03829254

Conditions: Advanced Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations: Cambridge University Hospitals NHS Foundation Trust (Addenbrookes Hospital) Cambridge, United Kingdom

Edinburgh Cancer Centre, Western General Hospital Edinburgh, United Kingdom

The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom

University College London Hospital London, United Kingdom

View Trial Details

Recruiting

Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

NCT05465954

Conditions: Astrocytoma, Glioblastoma, Glioma, +11 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Recruiting

A Multi-Arm, Platform Trial For Relapsed Neuroblastoma

NCT07334301

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +8 more
Locations: Sydney Children's Hospital (SCH) Sydney, Australia

St. Anna Children´s Hospital Vienna, Austria

Cliniques Universitaires Saint-Luc (CUSL) Brussels, Belgium

Starship Children's Hospital (SSH) Auckland, New Zealand

View all 23 locations

View Trial Details

Recruiting

Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma

NCT07240662

Conditions: Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg Heidelberg, Germany

View Trial Details

Recruiting

Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma

NCT05083754

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: Johns Hopkins Medical Institution Baltimore, Maryland, United States

View Trial Details

Recruiting

Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

NCT05106296

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +18 more
Locations: Augusta University, Georgia Cancer Center Augusta, Georgia, United States

View Trial Details

Recruiting

Antisecretory Factor Glioblastoma Phase 2

NCT05669820

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Skåne University Hospital Lund, Sweden

View Trial Details

Recruiting

Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors

NCT07161310

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations: Universitätsklinikum Frankfurt, Medizinische Klinik II, Hämatologie/Onkologie Frankfurt, Germany

View Trial Details

Recruiting

ACTengine® IMA203 Combined With mRNA-4203

NCT06946225

Conditions: Cutaneous Melanoma, Melanoma, Neoplasms, +15 more
Locations: University of California San Francisco San Francisco, California, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center New York, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions